Pharmacology and Drug Metabolism
A section of Metabolites (ISSN 2218-1989).
Section Information
This section of Metabolites is focused on the change in and/or occurrence of small molecule metabolites in in vitro and in vivo systems triggered by drugs and other xenobiotics. This ranges from classic metabolism studied in new compounds to new and emerging tools as well as toxicometabolomics studies, which investigate the fate of the foreign compounds as well as changes in endogenous molecules.
The section “Pharmacology and Drug Metabolism“ in Metabolites is focused on but not limited to:
- Toxicometabolomics (e.g., metabolism of xenobiotics besides answering related metabolomics questions);
- Biomarkers of xenobiotics exposure (e.g., metabolomics to allow for tracing an intake);
- Detailed characterization of xenobiotics metabolism in biofluids and tissues;
- Effect of endogenous microorganisms on biotransformation (e.g., influence of human microbiome on drug metabolism;
- Fate of xenobiotics in wastewater (e.g., impact of microorganisms on survival rate);
- Emerging tools in metabolomics and applied mass spectrometry (e.g., in drug metabolism);
- Drug–drug interactions or drug–food interactions on the metabolism of drugs and, in consequence, on therapeutic management;
- Adverse drug reactions in polypharmacy patients and related management (e.g., PGx-based guiding);
- New developments in toxicokinetics/pharmacokinetics;
- Metabolism and toxicity of compounds released from packaging materials (toxicokinetics and biomonitoring).
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Pharmacodynamics and Innovative Therapeutic Strategies for Metabolic Disorders (Deadline: 25 September 2026)
- Pharmacometabolomics in Drug Mechanism, Efficacy and Toxicity (Deadline: 31 October 2026)
- Driving Drug Discovery and Toxicology Forward with Multiomics (Deadline: 31 October 2026)
- Drug Metabolism and New Drug Development for Cancers—2nd Edition (Deadline: 15 December 2026)
- Toxicodynamics and Toxicokinetics of New Psychoactive Substances: From In Vitro Insights to In Vivo Impact (Deadline: 15 December 2026)
- Pharmacological Properties of Natural Products and Metabolites (Deadline: 20 December 2026)
- Bioactive Secondary Metabolites from Marine Macro- and Microorganisms (Deadline: 31 December 2026)
- Advancements in Mass Spectrometry Techniques for Metabolomic and Pharmaceutical Analysis (Deadline: 29 January 2027)
- Metabolomics: The Role of Natural Products in Drugs (Deadline: 31 January 2027)
- Pharmacological Modulation of Metabolic Pathways: Impact on Drug Development and Therapeutic Outcomes (Deadline: 15 February 2027)
- Recent Advances in Drug Metabolism and Transport (Deadline: 20 March 2027)